Bioinformatician for Skin Cancer Research in full- or part-time in Heidelberg bei Deutsches Krebsforschungszentrum

Deutsches Krebsforschungszentrum

Position: Bioinformatician for Skin Cancer Research in full- or part-time

Department: Digital Biomarkers for Oncology

Code number: 2023-0437

The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.

Skin cancer is one of the most common cancers in Europe, and malignant melanoma in particular causes the highest number of skin cancer-attributable deaths.

Our Junior Research Group "Digital Biomarkers for Oncology" (headed by Dr. Titus Brinker) specifically has a high expertise in early recognition of melanomas via artificial intelligence. In the latest work accepted for publication in Nature Communications, our team built an explainable artificial intelligence algorithm which explains itself like a dermatologist (preprint: https://arxiv.org/abs/2303.12806). Together with a team of motivated data scientists, dermatologists, biologists and an industry partner, we are now bringing this software to the patient, addressing technical limitations (uncertainty estimation, explainability, robustness of classifiers) in peer-reviewed publications along the way.

Job description:

In this capacity, we are looking for a motivated bioinformatician to join our efforts of improving early detection of skin cancer by addressing technically challenges scientifically, but also develop skills and take part in risk / usability management, which are core skills needed to bring data science to patients. We offer a vibrant environment in a highly skilled team and a lot of perspectives for successfully building your own scientific profile for an academic career or leading roles in industry.

Requirements:

Masters' degree in data science, bioinformatics or related fields
Strong motivation for cancer research
Strong interest in life sciences / working in interdisciplinary teams
Self-dependent work ethic
Fluency in English (some German would be great, but is not required)

We offer:

Excellent framework conditions: state-of-the-art equipment and opportunities for international networking at the highest level
Remuneration according to TV-L incl. occupational pension plan and capital-forming payments
30 days of vacation per year
Flexible working hours
Possibility of mobile work and part-time work
Family-friendly working environment, e.g. parent-child room, advisory services caring for elderly relatives
Sustainable travel to work: subsidized Germany job ticket
Unleash your full potential: targeted offers for your personal development to further develop your talents
Our Corporate Health Management Program offers a holistic approach to your well-being

Important notice:

The DKFZ is subject to the regulations of the Infection Protection Act (IfSG). As a consequence, only persons who present proof of immunity against measles may work at the DKFZ.

Earliest Possible Start Date: 01.02.2024

Duration: The position is limited to 18 months. An extension is possible.

The position is generally divisible.

Application Deadline: 11.01.2024

Contact:

Dr. Titus Brinker
Phone 0151/75084347

Please note that we do not accept applications submitted via email.

The DKFZ is committed to increase the proportion of women in all areas and positions in which women are underrepresented. Qualified female applicants are therefore particularly encouraged to apply.

Among candidates of equal aptitude and qualifications, a person with disabilities will be given preference.

To apply for a position please use our online application portal (https://www.dkfz.de/en/stellenangebote/index.php).

We ask for your understanding that we cannot return application documents that are sent to us by post (Deutsches Krebsforschungszentrum, Personalabteilung, Im Neuenheimer Feld 280, 69120 Heidelberg) and that we do not accept applications submitted via email. We apologize for any inconvenience this may cause.